Sep 30, 2019

ANI Pharmaceuticals Q3 2019 Earnings Report

Total Revenue
$51.3M
Previous year: $50.7M
+1.3%
EPS
$1.23
Previous year: $1.29
-4.7%
Gross Profit
$36.3M
Previous year: $35.1M
+3.5%
Cash and Equivalents
$59.7M
Previous year: $44.1M
+35.2%
Free Cash Flow
$20.3M
Previous year: $6.95M
+191.8%
Total Assets
$457M
Previous year: $439M
+3.9%

ANI Pharmaceuticals

ANI Pharmaceuticals

ANI Pharmaceuticals Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income